Radiation

NASA Sets Live Launch Coverage for Laser Communications Demonstration

Tuesday, November 30, 2021 - 8:30pm

WASHINGTON, Nov. 30, 2021 /PRNewswire/ -- NASA is taking a step toward the next era of space communications with the launch of its Laser Communications Relay Demonstration (LCRD) on Sunday, Dec. 5.

Key Points: 
  • WASHINGTON, Nov. 30, 2021 /PRNewswire/ -- NASA is taking a step toward the next era of space communications with the launch of its Laser Communications Relay Demonstration (LCRD) on Sunday, Dec. 5.
  • Live coverage of the launch is scheduled to air on NASA Television, the agency's website , and the NASA App beginning at 3:30 a.m. EST.
  • STP-3 will launch on a United Launch Alliance (ULA) Atlas V rocket from Cape CanaveralSpaceForce Station in Florida.
  • Take an inside look into the development of LCRD with a laser communications show from NASA EDGE.

Blue Earth Diagnostics Highlights Axumin® (Fluciclovine F 18) Presentation at Upcoming 22nd Annual Scientific Meeting in Urologic Oncology (SUO)

Tuesday, November 30, 2021 - 1:30pm

The Society of Urologic Oncology sponsors this highly interactive meeting where attendees participate in discussions led by internationally renowned urologic oncologists, medical oncologists, and scientists.

Key Points: 
  • The Society of Urologic Oncology sponsors this highly interactive meeting where attendees participate in discussions led by internationally renowned urologic oncologists, medical oncologists, and scientists.
  • The meeting includes state-of-the-art translational topics on prostate, kidney, and bladder cancer, as well as strategies in urologic oncology will be discussed.
  • Blue Earth Diagnostics invites participants at the 22nd Annual Scientific Meeting in Urologic Oncology to attend the presentation above and visit the Blue Earth Diagnostics Exhibit Booth.
  • Blue Earth Diagnostics expanding oncology portfolio encompasses a variety of disease states, including prostate cancer and neuro-oncology.

Silverlon Receives FDA Breakthrough Device Designation for Radiation Dermatitis and Cutaneous Radiation Injury

Tuesday, November 30, 2021 - 1:55pm

"This important FDA Breakthrough Designation has been 20 years in the making and is the ultimate validation for Silverlon," said Raul Brizuela, president and CEO of Argentum Medical.

Key Points: 
  • "This important FDA Breakthrough Designation has been 20 years in the making and is the ultimate validation for Silverlon," said Raul Brizuela, president and CEO of Argentum Medical.
  • "Receiving this designation will expedite our efforts to bring Silverlon to patients with radiation dermatitis and cutaneous radiation injury."
  • The indications for use of Silverlon Wound Contact, Burn Contact Dressings granted designation by the FDA are for application up to 7 days for radiation dermatitis and cutaneous radiation injury through dry desquamation or not requiring skin grafting.
  • The contract with BARDA advanced development of radiation exposure wound technology and allowed researchers to explore how Silverlon can treat low-grade and acute skin radiation injuries.

Outlook on the Lymphoma Treatment Global Market to 2026 - by Type, Test Type, Drug and Region - ResearchAndMarkets.com

Tuesday, November 30, 2021 - 12:46pm

The increasing prevalence of non-Hodgkin lymphoma across the globe represents one of the key factors driving the growth of the market.

Key Points: 
  • The increasing prevalence of non-Hodgkin lymphoma across the globe represents one of the key factors driving the growth of the market.
  • Key Questions Answered in This Report:
    How has the global lymphoma treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lymphoma treatment market?
  • What is the structure of the global lymphoma treatment market and who are the key players?

IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer

Tuesday, November 30, 2021 - 12:05pm

The combination of MVP-S may help overcome this mechanism of resistance and provide benefit to these women while limiting adverse events.

Key Points: 
  • The combination of MVP-S may help overcome this mechanism of resistance and provide benefit to these women while limiting adverse events.
  • She added that Women with HR+/HER2- breast cancer are in need of treatments that are effective and allow a good quality of life.
  • This investigator-initiated clinical study is a Phase 1b, non-randomized, open-label study to evaluate the combination of maveropepimut-S (MVP-S, formerly named DPX-Survivac) and an aromatase inhibitor with/without radiotherapy or cyclophosphamide (CPA) prior to surgery.
  • Across the three arms of this study, MVP-S will be evaluated in 18 subjects with resectable, non-metastatic HR+/HER2- breast cancer.

St. Baldrick's Foundation Joins the Worldwide Movement Called #GivingTuesday to #GiveKidsALifetime

Tuesday, November 30, 2021 - 11:00am

It's #GivingTuesday - a global generosity movement unleashing the power of radical generosity - and the St. Baldrick's Foundation , the largest non-government funder of childhood cancer research grants has a goal to raise $100,000 to conquer kids' cancer!

Key Points: 
  • It's #GivingTuesday - a global generosity movement unleashing the power of radical generosity - and the St. Baldrick's Foundation , the largest non-government funder of childhood cancer research grants has a goal to raise $100,000 to conquer kids' cancer!
  • Yes, there are so many worthy causes, but what could be more important than saving a life?
  • St. Baldrick's Honored Kid, Julia , started fighting a brain tumor when she was only 8.
  • "We should help people and give back to others all the blessings God has given us," says Julia.

COVID-19 During Pregnancy Doesn't Harm Baby's Brain

Tuesday, November 30, 2021 - 10:00am

However, little is known about the possible consequences for an unborn child if the mother is infected during pregnancy.

Key Points: 
  • However, little is known about the possible consequences for an unborn child if the mother is infected during pregnancy.
  • The aim of our study was to fill this gap in knowledge regarding the impact of a maternal SARS-CoV-2 infection on fetal brain development."
  • Dr. Stcklein and colleagues used fetal MRI to study 33 patients with COVID-19 infection during pregnancy.
  • "Since the impact of severe infection on brain development in the fetus has not been conclusively determined, active protection against SARS-CoV-2 infection during pregnancy remains important," she said.

Popular Blood Thinners May Lead to Brain Bleeding after Head Injury

Tuesday, November 30, 2021 - 10:00am

Intracranial hemorrhage occurs when blood vessels within the brain rupture, releasing blood into the brain tissue.

Key Points: 
  • Intracranial hemorrhage occurs when blood vessels within the brain rupture, releasing blood into the brain tissue.
  • In a delayed traumatic intracranial hemorrhage, bleeding in the brain occurs after the initial trauma, usually within 48 hours, after an initial negative head CT.
    High blood pressure, head injury and the use of blood thinners are known causes of intracranial hemorrhage.
  • As the population ages, the prevalence of patients taking blood thinners is increasing.
  • Adults taking blood thinners who suffer head trauma typically undergo CT imaging of the brain.

US Nuclear Corp. Discusses 3rd Quarter Results and Launch of New Climate Drones with The Stock Day Podcast

Monday, November 29, 2021 - 5:29pm

Jolly began the interview by commenting on the Company's third quarter results, which included a significant increase in gross revenue and reduction in losses.

Key Points: 
  • Jolly began the interview by commenting on the Company's third quarter results, which included a significant increase in gross revenue and reduction in losses.
  • "China was unable to sign the COP26 climate change agreement because China is very dependent on coal," he added.
  • Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets.
  • The Stock Day Podcast is the number one radio show of its kind in America.

United Imaging Blazes a Trail, Helping Customers "Future Proof"

Monday, November 29, 2021 - 2:00pm

What impact do extra processes, wasteful steps, and a lack of standardization have on consistency in practice, and how can variability be reduced?

Key Points: 
  • What impact do extra processes, wasteful steps, and a lack of standardization have on consistency in practice, and how can variability be reduced?
  • United Imaging is offering this symposium as part of a broader theme on "future-proofing," and how they help imaging providers grow, innovate, and get better investment protection for their equipment purchases.
  • At United Imaging, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment.
  • With a cutting-edge digital portfolio and a mission of broader access to healthcare for all, we help drive industry progress and bold change.